|
|
 |
|
Viewing report
|
|
|
|
Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform
Cutting Edge Information, Aug 2009, Pages: 123
Strengthen payer relationships through communication:
Of all factors contributing to product success, payer access could be the most critical. Without the best reimbursement status for a drug, the investments your company made during drug development may end up as a lost cause. Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform examines the processes, strategies and best practices that industry leaders have implemented to build strong relationships and gain payer access.
This report is a tool for companies to adjust their strategies to meet growing payer demands and facilitate the reimbursement process:
Improve payer communication and formulary submission success.
Metrics on payer targeting, communication methods and timing guide the strategic recommendations leading to healthier and more lucrative relationships for pharmaceutical companies with payers.
Increase the efficiency of your managed market department:
Analyze benchmarking data from surveyed companies on organizational structure, headcount distribution for various functions within the managed markets group, account distribution and resource allocation.
Understand the impact of potential healthcare reform on managed markets teams
Although there are no clear-cut solutions to healthcare reform, this report provides recommendations for drug companies to prepare for both minor and major changes to the healthcare system. Interviewed pharmaceutical executives discuss their strategic responses to potential changes that could be on the managed markets horizon. Cutting Edge Information's analysts designed the practices contained within to help managed markets teams develop strategies to respond effectively to various scenarios that could emerge.
Is your drug getting the best reimbursement possible? Are you prepared for radical healthcare policy changes? Even if you’ve developed the world’s safest and most effective drug, market uptake is no guarantee. What matters is gaining market access by building strong relationships with payer groups. Now more than ever, payers demand more: more data, more outcomes research, and more standardized submissions.
Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform gives you a fail-proof plan of action to meet payers’ needs avoiding costly delays and accelerating the reimbursement decisionmaking process. Follow strategic recommendations to position products with cost-effectiveness and value statements in mind; increase market access budgets and staff by using our detailed benchmarks and key performance indicators; validate drug price points; and understand how comparative effectiveness research (CER) is altering company strategy. We’ve also interviewed global pharma leaders for their perspectives on US healthcare reform. See what industry leaders are thinking about the latest payer relationship trends…and stay ahead of the curve.
You’ve invested so much time, energy and money into product development and launch. Don’t jeopardize your brand’s future by stumbling over reimbursement roadblocks! Start benefiting from our actionable insights today!
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Healthcare Market Access Management: Building Teams that Deliver Value to Payers
Building Strong Market Access Teams
Reimbursement in Europe and Indication-Specific Pricing
In Vitro Diagnostics: Development Through Postmarket
Personalized Medicine 2010
Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure
Healthcare Reform in China
Clinical Operations: Benchmarking Per-Patient Trial Costs, Staffing and Adaptive Design
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market
Emerging Markets Clinical Development Series: Africa
|
|
|
|
